Erste Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Erste Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35M	Hold	4,300	–	–	0.01%	427
2026 Q1	$828K	Hold	4,300	–	–	0.01%	460
2025 Q4	$839K	Hold	4,300	–	–	0.01%	446
2025 Q3	$744K	Hold	4,300	–	–	0.01%	435
2025 Q2	$491K	Hold	4,300	–	–	﹤0.01%	633
2025 Q1	$463K	Hold	4,300	–	–	0.01%	436
2024 Q4	$470K	Hold	4,300	–	–	0.01%	442
2024 Q3	$419K	Hold	4,300	–	–	0.01%	454
2024 Q2	$354K	Hold	4,300	–	–	﹤0.01%	445
2024 Q1	$306K	Hold	4,300	–	–	﹤0.01%	458
2023 Q4	$309K	Hold	4,300	–	–	﹤0.01%	458
2023 Q3	$264K	Hold	4,300	–	–	﹤0.01%	463
2023 Q2	$312K	Hold	4,300	–	–	0.01%	460
2023 Q1	$307K	Hold	4,300	–	–	0.01%	470
2022 Q4	$291K	Sell	4,300 -2,593	-38%	-$169K	0.01%	461
2022 Q3	$368K	Hold	6,893	–	–	0.01%	451
2022 Q2	$380K	Hold	6,893	–	–	0.01%	456
2022 Q1	$500K	Hold	6,893	–	–	0.01%	436
2021 Q4	$700K	Hold	6,893	–	–	0.01%	392
2021 Q3	$602K	Hold	6,893	–	–	0.01%	385
2021 Q2	$581K	Hold	6,893	–	–	0.01%	391
2021 Q1	$641K	Hold	6,893	–	–	0.02%	369
2020 Q4	$425K	Sell	6,893 -4,649	-40%	-$265K	0.01%	401
2020 Q3	$690K	Hold	11,542	–	–	0.02%	329
2020 Q2	$814K	Hold	11,542	–	–	0.03%	303
2020 Q1	$513K	Hold	11,542	–	–	0.03%	305
2019 Q4	$769K	Hold	11,542	–	–	0.03%	299
2019 Q3	$712K	Hold	11,542	–	–	0.04%	295
2019 Q2	$821K	Hold	11,542	–	–	0.04%	263
2019 Q1	$889K	Hold	11,542	–	–	0.05%	258
2018 Q4	$986K	Buy	+11,542	New	+$1.23M	0.07%	237

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Erste Asset Management's LGND Position: Q2 2026 in Review

Erste Asset Management held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 4,300 shares worth $1.35M. The position accounts for 0.01% of the portfolio, ranked #427.

Erste Asset Management first reported a position in LGND in Q4 2018 and has held it in 31 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Erste Asset Management held 4,300 shares of Ligand Pharmaceuticals worth $1.35M as of Q2 2026.
Erste Asset Management left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
Ligand Pharmaceuticals made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #427 holding.
Erste Asset Management first reported a position in Ligand Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.